Asian Science Citation Index is committed to provide an authoritative, trusted and significant information by the coverage of the most important and influential journals to meet the needs of the global scientific community.  
ASCI Database
308-Lasani Town,
Sargodha Road,
Faisalabad, Pakistan
Fax: +92-41-8815544
Contact Via Web
Suggest a Journal
Articles by Fatemeh Soleymani
Total Records ( 1 ) for Fatemeh Soleymani
  Fatemeh Soleymani and Mohammad Abdollahi
  Rational drug use cannot be identified without a method of measurement and a reference standard that are necessary to measure the impact of interventions. Over the past few years, the International Network for Rational Use of Drug (INRUD) and the WHO Action Program on Essential Drugs have closely collaborated in developing countries to test a set of 5 prescribing indicators to measure some key aspects of prescribing. Collecting the prescriptions data and analyzing them is one way for measuring the above indicators. In Iran, National Committee of Rational Use of Drug (NCRUD) and local committees affiliated to 42 universities of medical sciences were established by Food and Drug Organisation in 1996 throughout the country to implement and promote rational use of drugs. Here we aimed to examine all prescribing patterns in Iran in terms of irrational use of drugs. To look at the pattern of physicians’ prescription, the subcommittee of computer and data analysis of NCRUD was set up to initiate and develop a data warehouse and application software. The intended outcome of such efforts was to gather and analyze prescription data for measuring RUD indicators and strategies to promote rational drug use. After development, data ware house, called “Noskhehpardaz (RX Analyzer),” was tested for its validity and reliability in a pilot study in Mashhad University of Medical Sciences in 1996. More than 200 million prescriptions, equaling about to 70% of all prescriptions in the country, were collected nationally and analyzed by RX Analyzer software. Mean items per prescription was 4. 25 in 1998 and with the downward trend were 3.22 in 2009. Mean cost of prescriptions increased from 0.56 US$ in 1998 to 4.19 US$ in 2009. Availability of information on prescriptions has facilitated audit and feedback suggesting that policy makers should have to consider these data in their decisions.
Copyright   |   Desclaimer   |    Privacy Policy   |   Browsers   |   Accessibility